The cancer gene MYC camouflages tumors by suppressing alarm signals that normally activate the immune system. This finding from a new study offers a promising way to improve existing cancer therapies ...
A mysterious RNA molecule found only in breast cancer led researchers on a six-year hunt that uncovered an entire hidden layer of cancer biology. The story began with T3p, a tiny RNA molecule found in ...
After being described in 2018, researchers knew they had something interesting with T3p, a single small RNA found in breast ...
In individuals who started antiretroviral therapy during acute HIV infection, the proliferative capacity of HIV-specific CD8+ ...
Techno-Science.net on MSN
Lupus: Discovery of markers to identify patients at highest risk
An international team, led by Paul R. Fortin of Université Laval, has just identified three markers that would allow for establishing, right at the time of diagnosis, the risk of a lupus ...
Immune Checkpoint Blockade (ICB) has reshaped cancer care and can deliver durable remission in malignancies such as melanoma and non-small cell lung cancer.
MYC‑driven tumors silence innate immune alarms by clearing R‑loop–derived signals, exposing a new therapeutic angle for targeting MYC without broad inhibition.
Delve Bio, a pioneer in metagenomic next-generation sequencing (mNGS) for infectious diseases, today announced data published in Open Forum Infectious Diseases shows earlier use of comprehensive ...
By targeting proteins used to splice genes, UC San Diego researchers have unlocked a new approach to treating triple-negative ...
Your sperm may age faster than you think—researchers uncovered a molecular clock that could affect your child’s health before ...
The company plans to begin enrolling the trial next quarter across eight US sites to test the vaccine as a monotherapy and in combination with Keytruda.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback